These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29932230)

  • 1. Effects of selenium supplementation on expression of SEPP1 in mRNA and protein levels in subjects with and without metabolic syndrome suffering from coronary artery disease: Selenegene study a double-blind randomized controlled trial.
    Gharipour M; Ouguerram K; Nazih EH; Salehi M; Behmanesh M; Roohafza H; Hosseini SM; Nezafati P; Dianatkhah M; Gharipour A; Haghjoo S; Sarrafzadegan N; Sadeghi M
    J Cell Biochem; 2018 Nov; 119(10):8282-8289. PubMed ID: 29932230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of a study protocol of a preliminary double-blind randomized controlled trial. Verifying effects of selenium supplementation on selenoprotein p and s genes expression in protein and mRNA levels in subjects with coronary artery disease: selenegene.
    Gharipour M; Sadeghi M; Behmanesh M; Salehi M; Roohafza H; Nezafati P; Khosravi E; Hosseini M; Keshvari M; Rouhi-Bourojeni H; Sarrafzadegan N
    Acta Biomed; 2019 Jan; 90(1):44-50. PubMed ID: 30889154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single nucleotide polymorphisms in SEPS1 and SEPP1 on expression in the protein level in metabolic syndrome in subjects with cardiovascular disease.
    Gharipour M; Ouguerram K; Nazih EH; Salehi M; Behmanesh M; Razavi R; Gharipour A; Diantkhah M; Sadeghi M
    Mol Biol Rep; 2019 Dec; 46(6):5685-5693. PubMed ID: 31542866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.
    Gharipour M; Sadeghi M; Salehi M; Behmanesh M; Khosravi E; Dianatkhah M; Haghjoo Javanmard S; Razavi R; Gharipour A
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28190280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice.
    Renko K; Werner M; Renner-Müller I; Cooper TG; Yeung CH; Hollenbach B; Scharpf M; Köhrle J; Schomburg L; Schweizer U
    Biochem J; 2008 Feb; 409(3):741-9. PubMed ID: 17961124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status.
    Méplan C; Nicol F; Burtle BT; Crosley LK; Arthur JR; Mathers JC; Hesketh JE
    Antioxid Redox Signal; 2009 Nov; 11(11):2631-40. PubMed ID: 19453253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Thyroid Peroxidase Antibody Titer in Response to Selenium Supplementation in Autoimmune Thyroiditis and the Influence of a Selenoprotein P Gene Polymorphism: A Prospective, Multicenter Study in China.
    Wang W; Mao J; Zhao J; Lu J; Yan L; Du J; Lu Z; Wang H; Xu M; Bai X; Zhu L; Fan C; Wang H; Zhang H; Shan Z; Teng W
    Thyroid; 2018 Dec; 28(12):1674-1681. PubMed ID: 30398407
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects.
    Xia Y; Hill KE; Li P; Xu J; Zhou D; Motley AK; Wang L; Byrne DW; Burk RF
    Am J Clin Nutr; 2010 Sep; 92(3):525-31. PubMed ID: 20573787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium.
    Persson-Moschos M; Alfthan G; Akesson B
    Eur J Clin Nutr; 1998 May; 52(5):363-7. PubMed ID: 9630388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial.
    Hurst R; Armah CN; Dainty JR; Hart DJ; Teucher B; Goldson AJ; Broadley MR; Motley AK; Fairweather-Tait SJ
    Am J Clin Nutr; 2010 Apr; 91(4):923-31. PubMed ID: 20181815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms that affect selenium status and response to selenium supplementation in United Kingdom pregnant women.
    Mao J; Vanderlelie JJ; Perkins AV; Redman CW; Ahmadi KR; Rayman MP
    Am J Clin Nutr; 2016 Jan; 103(1):100-6. PubMed ID: 26675765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study).
    Méplan C; Crosley LK; Nicol F; Beckett GJ; Howie AF; Hill KE; Horgan G; Mathers JC; Arthur JR; Hesketh JE
    FASEB J; 2007 Oct; 21(12):3063-74. PubMed ID: 17536041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
    Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
    Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.
    Rayman MP; Blundell-Pound G; Pastor-Barriuso R; Guallar E; Steinbrenner H; Stranges S
    PLoS One; 2012; 7(9):e45269. PubMed ID: 23028897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism.
    Nourbakhsh M; Ahmadpour F; Chahardoli B; Malekpour-Dehkordi Z; Nourbakhsh M; Hosseini-Fard SR; Doustimotlagh A; Golestani A; Razzaghy-Azar M
    J Trace Elem Med Biol; 2016 Mar; 34():10-4. PubMed ID: 26854239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial.
    Burk RF; Hill KE; Motley AK; Byrne DW; Norsworthy BK
    Am J Clin Nutr; 2015 Nov; 102(5):1126-33. PubMed ID: 26468123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse Associations of Plasma Selenium Concentrations and SELENOP Gene Polymorphism with Metabolic Syndrome and Its Components.
    Zhou L; Luo C; Yin J; Zhu Y; Li P; Chen S; Sun T; Xie M; Shan Z; Cao B; Hu X; Rong Y; Yang W; Li X; Tan A; Liu L
    Oxid Med Cell Longev; 2020; 2020():5343014. PubMed ID: 32377302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis.
    Al-Taie OH; Uceyler N; Eubner U; Jakob F; Mörk H; Scheurlen M; Brigelius-Flohe R; Schöttker K; Abel J; Thalheimer A; Katzenberger T; Illert B; Melcher R; Köhrle J
    Nutr Cancer; 2004; 48(1):6-14. PubMed ID: 15203372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome.
    Talari HR; Rafiee M; Farrokhian A; Raygan F; Bahmani F; Darooghegi Mofrad M; Hamidian Y; Tamtaji OR; Karamali F; Asemi Z
    Ann Nutr Metab; 2016; 69(1):41-50. PubMed ID: 27450552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium Supplementation Affects Insulin Resistance and Serum hs-CRP in Patients with Type 2 Diabetes and Coronary Heart Disease.
    Farrokhian A; Bahmani F; Taghizadeh M; Mirhashemi SM; Aarabi MH; Raygan F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Apr; 48(4):263-8. PubMed ID: 26743526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.